Sofgen Pharma S.A. (PROCF) — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$409.9M

Net Income/Loss (FY2022)

$42.5M

Total Assets (FY2022)

$460.2M

Total Equity (FY2022)

-$1.9M

Cash Flows from Operating Activities (FY2022)

$14.1M

Source: Sofgen Pharma S.A. 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.